Antibodies to Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis in the sera of ankylosing spondylitis patients with/without iritis and enthesitis
- PMID: 7788169
- DOI: 10.1093/rheumatology/34.5.418
Antibodies to Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis in the sera of ankylosing spondylitis patients with/without iritis and enthesitis
Abstract
IgM, IgG and IgA class serum antibodies against the whole Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis bacteria, as well as against K. pneumoniae and E. coli lipopolysaccharides (LPSs) were studied earlier in the sera of 98 patients with ankylosing spondylitis (AS) and in 102 healthy blood donors by enzyme immunoassay. In this study the patients were divided into groups according to the clinical picture, i.e. presence or absence of iritis and enthesitis. The previous major finding of increased IgA class antibody levels against the whole K. pneumoniae bacteria in AS patients when compared to the healthy controls was not specifically associated with any single patient group in the present study. However, the patients with iritis had higher levels of IgA class antibodies to LPS of K. pneumoniae and E. coli when compared to the patients without iritis. In addition, the patients without enthesitis had higher level of IgG class antibodies against whole K. pneumoniae bacteria compared to the patients with enthesitis. The increased IgA class antibody levels against K. pneumoniae and E. coli LPS in AS patients with iritis may reflect an inflammatory process in the gut area. Furthermore, there were certain other differences in the immunological parameters between the AS patients with and without iritis or enthesitis and the possibility that they reflect different mechanisms involved in the disease processes cannot be excluded.
Similar articles
-
Antibodies to Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis in the sera of patients with axial and peripheral form of ankylosing spondylitis.Br J Rheumatol. 1995 May;34(5):413-7. doi: 10.1093/rheumatology/34.5.413. Br J Rheumatol. 1995. PMID: 7788168 Clinical Trial.
-
Antibodies to Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis in ankylosing spondylitis: effect of sulfasalazine treatment.J Rheumatol. 1994 Nov;21(11):2082-7. J Rheumatol. 1994. PMID: 7869314 Clinical Trial.
-
Similarly increased serum IgA1 and IgA2 subclass antibody levels against Klebsiella pneumoniae bacteria in ankylosing spondylitis patients with/without extra-articular features.Br J Rheumatol. 1996 Feb;35(2):125-8. doi: 10.1093/rheumatology/35.2.125. Br J Rheumatol. 1996. PMID: 8612022
-
Association between Klebsiella pneumoniae and ankylosing spondylitis: A systematic review and meta-analysis.Int J Rheum Dis. 2022 Apr;25(4):422-432. doi: 10.1111/1756-185X.14283. Epub 2022 Jan 12. Int J Rheum Dis. 2022. PMID: 35019225
-
Klebsiella antibodies in ankylosing spondylitis and Proteus antibodies in rheumatoid arthritis.Br J Rheumatol. 1988;27 Suppl 2:72-85. doi: 10.1093/rheumatology/xxvii.suppl_2.72. Br J Rheumatol. 1988. PMID: 3042077 Review.
Cited by
-
PROBIOTICS - A PROBABLE THERAPEUTIC AGENT FOR SPONDYLOARTHROPATHY.Int J Probiotics Prebiotics. 2017;12(2):57-68. Epub 2017 Aug 21. Int J Probiotics Prebiotics. 2017. PMID: 31007634 Free PMC article.
-
Why HLA-B27? My thirty-year quest: the Friedenwald lecture.Invest Ophthalmol Vis Sci. 2011 Sep 29;52(10):7712-5, 7711. doi: 10.1167/iovs.11-8247. Invest Ophthalmol Vis Sci. 2011. PMID: 21960642 Free PMC article. No abstract available.
-
Infectious background of patients with a history of acute anterior uveitis.Ann Rheum Dis. 2002 Nov;61(11):1012-6. doi: 10.1136/ard.61.11.1012. Ann Rheum Dis. 2002. PMID: 12379526 Free PMC article.
-
Time for a gut check: evidence for the hypothesis that HLA-B27 predisposes to ankylosing spondylitis by altering the microbiome.Arthritis Rheum. 2011 Nov;63(11):3195-8. doi: 10.1002/art.30558. Arthritis Rheum. 2011. PMID: 21792826 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous